Case Based Peer Perspectives

Case-Based Peer Perspectives

Targeted Oncology presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.

A 72-Year-Old Man with R/R Chronic Lymphocytic Leukemia

May 25th 2022

Dr Catherine Coombs discusses considerations for treatment selection in the context of a patient case with relapsed/refractory chronic lymphocytic leukemia.

A 67-Year-Old Man with Primary Myelofibrosis

May 17th 2022

Raajit Rampal, MD, PhD, reviews the case of a 67-year-old man with primary myelofibrosis.

A 60-Year-Old Man with Uncontrolled Polycythemia Vera

May 12th 2022

Expert perspectives on the diagnosis and management of uncontrolled polycythemia vera in a 60-year-old man.

A 54-Year-Old Woman With Multiple Myeloma

May 9th 2022

Expert hematologist-oncologist Ajay Nooka, MD, MPH, FACP, centers discussion around a clinical case to review updates in the treatment of newly diagnosed multiple myeloma.

An 81-Year-Old Man with Multiple Myeloma

April 29th 2022

Expert hematologist-oncologist Rafael Fonseca, MD, reviews the diagnosis and management of an 81-year-old-man who presents with transplant-ineligible multiple myeloma.

A 59-Year-Old Female With Lung Cancer

April 26th 2022

Expert oncologist Zofia Piotrowska, MD, reviews the case of a 59-year-old woman who is diagnosed and treated for EGFR exon 20–positive non–small cell lung cancer.

A 64-Year-Old Male With Lung Cancer

April 21st 2022

Expert Joel Neal, MD, PhD, speaks to the management of a 64-year-old man diagnosed with EGFR exon20 insertion–positive NSCLC.

A 76-Year-Old Woman with Myelofibrosis

April 20th 2022

John Mascarenhas, MD, reviews the case of a 76-year-old woman with myelofibrosis and her treatment with pacritinib.

A 52-Year-Old Woman with Intermediate-Risk Primary Myelofibrosis

April 19th 2022

Srdan Verstovsek, MD, PhD, provides insight on treatment of primary myelofibrosis, including ruxolitinib, and comments on some of the challenges, unmet needs, and future directions in the field.

A 70-Year-Old Woman with Newly Diagnosed Chronic Lymphocytic Leukemia

April 18th 2022

Dr John Allan reviews the case of a 70-year-old woman with newly diagnosed CLL and discusses current treatment strategies and challenges.